Please login to the form below

Not currently logged in
Email:
Password:

Senior AstraZeneca exec jumps ship to small biotech

Briggs Morrison unexpectedly leaves the UK firm

AstraZeneca's chief medical officer Briggs Morrison is leaving the company, according to a statement from the Anglo-Swedish company.

He will leave the world's eight largest pharma firm to join a much smaller, privately owned biotech company, whose identity has not yet been publicly revealed.

AstraZeneca's chief executive, Pascal Soriot, will take over the job of late-stage drug development on an interim basis, according to news reports. 

Meanwhile Elisabeth Björk, an associate professor of medicine at Uppsala university and leads cardiovascular and metabolic drug development at AZ, now becomes acting chief medical officer.

Morrison's departure has surprised analysts as he joined AstraZeneca just three years ago and became a key member of the Soirot's new executive team. 

Colin White, an analyst at Datamonitor Healthcare, said: “It is surprising because he was brought in by Soriot and has been a key part of Soriot's leadership team.”

12 months ago the firm successfully rejected an $118bn takeover attempt from the US pharma giant Pfizer, saying it wanted to take an independent path. 

12th June 2015

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides powerful, insight-driven, healthcare communication services to the pharmaceutical industry across the globe, with a focus...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...